BA vs ENTA · P/E 89, rev $89.46B vs rev $65.3M
The Boeing Company (BA) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the BA and ENTA stock pages for the full models.
Not investment advice.